J&J Medical Connect
CAPLYTA®

(lumateperone)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

CAPLYTA - Ingredients

Last Updated: 11/05/2026

SUMMARY  

  • The active ingredient in CAPLYTA is lumateperone. Lumateperone is an atypical antipsychotic present as lumateperone tosylate salt.1  
  • Each capsule contains:
    • 42 mg of lumateperone (equivalent to 60 mg of lumateperone tosylate), or
    • 21 mg of lumateperone (equivalent to 30 mg of lumateperone tosylate), or
    • 10.5 mg of lumateperone (equivalent to 15 mg of lumateperone tosylate).
  • The capsules include the following inactive ingredients: croscarmellose sodium, gelatin, magnesium stearate, mannitol, and talc.
  • Colorants include FD&C blue #1 and red #3 (42 mg), FDA/E172 black iron oxide, FDA/E172 red iron oxide and FD&C red #3 (10.5 mg), and titanium dioxide (42 mg, 21 mg and 10.5 mg). 

product packaging

  • CAPLYTA capsules are available in three strengths:1
    • 42 mg: Blue cap and opaque white body imprinted with “ITI-007 42 mg”
    • 21 mg: Opaque white cap and body imprinted with “ITI-007 21 mg”
    • 10.5 mg: Opaque light pink cap and body imprinted with “ITI-007 10.5 mg”

LITERATURE SEARCH

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, and DERWENT® (and/or other resources, including internal/external databases) was conducted on 27 October 2026.

REFERENCES

1. CAPLYTA® (lumateperone) [Prescribing Information]. Titusville, NJ: Intra-Cellular Therapies, Inc; https://www.jnjlabels.com/package-insert/product-monograph/prescribing-information/CAPLYTA-pi.pdf.

 

Would you like to clear and leave your conversation? Message history will be lost.